Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Sotio Biotech Inc.
City of Hope Medical Center
NeoImmuneTech
Rush University Medical Center
AstraZeneca
I-Mab Biopharma US Limited
Merck Sharp & Dohme LLC
Pfizer
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
Institut Bergonié
Rutgers, The State University of New Jersey
Numab Therapeutics AG
Pfizer
NextCure, Inc.
Elevation Oncology
AstraZeneca
Stanford University
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
BeiGene
Five Prime Therapeutics, Inc.
Sellas Life Sciences Group
Mundipharma Research Limited
Sandoz
Pfizer
NantCell, Inc.
Avera McKennan Hospital & University Health Center
ADC Therapeutics S.A.
University of Washington
Exelixis
pharmaand GmbH
Pfizer
CytomX Therapeutics
University Hospital, Ghent
Hoffmann-La Roche
pharmaand GmbH
Hoffmann-La Roche
AstraZeneca
OncoNano Medicine, Inc.
Fred Hutchinson Cancer Center
Herlev Hospital
Tesaro, Inc.
Tesaro, Inc.
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research